Skip to main content

OptimizeRx Corp

corporate_fare Company Profile

OptimizeRx Corp

OPRX·NASDAQ·Trade & Services·CIK 0001448431

OptimizeRx is a digital healthcare technology company that helps life sciences brands engage with, market to, and support patients and healthcare providers. Founded in 2006 in Rochester, Michigan, as a Nevada corporation, the company initially delivered messages like coupons and co-pays to physicians and pharmacists through electronic health record (EHR) systems and ePrescribing (eRx) platforms. Over time, OptimizeRx expanded its solutions to deliver a wider variety of health-related information across more platforms and to broader audiences. The company enhanced its original financial messaging solution by incorporating artificial intelligence (AI)-driven tools. Its current AI-enabled Dynamic Audience Activation Platform (DAAP) identifies precise healthcare provider (HCP) audiences and estimates when these HCPs will see brand-eligible patients. In 2023, OptimizeRx acquired Healthy Offers, Inc. (d/b/a "Medicx" or "Medicx Health"), which expanded its capabilities to include direct-to-consumer (DTC) marketing. This DTC marketing uses Medicx Health's patent-protected Micro-Neighborhood® Targeting (MNT) solution. MNT uses de-identified claims data to identify and target geographies where eligible patients live, rather than individual patients, providing a privacy-centric approach for brand manufacturers. With the integration of DTC marketing, OptimizeRx's life sciences brand customers can now reach both HCP and patient audiences across its omnichannel network. The company currently offers diverse tech-enabled marketing solutions that use machine learning algorithms to find the best audience in the correct channels at the right time.

OptimizeRx Corp (NASDAQ:OPRX) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 17 items for OPRX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 17 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for OPRX spans 10-Q, 8-K, DEFA14A, DEF 14A.

Recent high-impact activity:

  • OptimizeRx 10-Q: Q3 Revenue Down 17%, Net Income $1.2M, Material Weakness Persists
  • OptimizeRx Cuts FY26 Revenue Guidance to $87-$93M Despite Q3 EBITDA Beat
  • OptimizeRx Posts 20c Adjusted EPS for Third Quarter
  • OptimizeRx CFO Stelmakh to Exit; D'Silva and Favazza Promoted; Q2 Revenue Falls 30%
  • OptimizeRx Q2 Revenue Falls 30% to $20.5M, Reaffirms FY26 Guidance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$109.43M
Net Income
$5.13M
Diluted EPS
$0.27
Op. Cash Flow
$18.71M
Free Cash Flow
$18.66M
Gross Profit
$73.59M
Operating Income
$11.69M
Cash & Equivalents
$23.36M
Total Debt
$25.68M
Debt / Equity
0.20×
Net Margin
4.7%
Shares Outstanding
18.76M sh
Source: 10-K · filed 2026-03-12 · accession 0001448431-26-000005

Short Interest & Short Volume

9.75 days to cover

FINRA reported short interest of 1,187,196 shares in OPRX as of the October 30, 2026 settlement, a 10.1% increase from the prior period — about 9.8 days to cover at its recent average daily volume. On November 20, 2026, 54.2% of OPRX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,187,196 shares as of October 30, 2026
Change vs prior period▲ 10.1%
Days to cover9.75 at avg daily volume of 121,784
Daily short volume (FINRA facilities)54.2% of 68,767 shares on November 20, 2026
5-day average short volume46.6%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with O →
$7.34 +0.44% today
52-week range · as of 2026-11-13 $4.54 – $16.37
Market cap
$126.68M
Volume
186.7K (0.9× avg)
3-mo avg 218.1K
Live data · 2026-11-22 03:44 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed OPRX - Latest Insights

OPRX
Nov 13, 2026, 4:07 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $7.34
Real-time Price: $7.34 info
Change: +$0.0021 (+0.03%) info
Market Cap: $126.676M info
OPRX
Nov 13, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.34
Real-time Price: $7.34 info
Change: +$0.0021 (+0.03%) info
Market Cap: $126.676M info
OPRX
Nov 11, 2026, 4:01 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $8.91
Real-time Price: $7.34 info
Change: -$1.57 (-18%) info
Market Cap: $126.676M info
OPRX
Aug 12, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.04
Real-time Price: $7.34 info
Change: +$0.3021 (+4%) info
Market Cap: $126.676M info
OPRX
Aug 12, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $7.04
Real-time Price: $7.34 info
Change: +$0.3021 (+4%) info
Market Cap: $126.676M info
OPRX
Jun 12, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.23
Real-time Price: $7.34 info
Change: +$2.11 (+40%) info
Market Cap: $126.676M info
OPRX
Jun 05, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.11
Real-time Price: $7.34 info
Change: +$2.23 (+44%) info
Market Cap: $126.676M info
OPRX
Jun 01, 2026, 7:30 AM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $5.17
Real-time Price: $7.34 info
Change: +$2.17 (+42%) info
Market Cap: $126.676M info
OPRX
May 13, 2026, 4:04 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.92
Real-time Price: $7.34 info
Change: +$2.42 (+49%) info
Market Cap: $126.676M info
OPRX
May 12, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $6.10
Real-time Price: $7.34 info
Change: +$1.24 (+20%) info
Market Cap: $126.676M info
OPRX
May 12, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $5.75
Real-time Price: $7.34 info
Change: +$1.59 (+28%) info
Market Cap: $126.676M info
OPRX
May 12, 2026, 4:01 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $6.34
Real-time Price: $7.34 info
Change: +$1.00 (+16%) info
Market Cap: $126.676M info
OPRX
Apr 30, 2026, 7:15 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $6.43
Real-time Price: $7.34 info
Change: +$0.9121 (+14%) info
Market Cap: $126.676M info
OPRX
Apr 08, 2026, 5:46 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.07
Real-time Price: $7.34 info
Change: +$0.2721 (+4%) info
Market Cap: $126.676M info
OPRX
Mar 12, 2026, 4:03 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $5.93
Real-time Price: $7.34 info
Change: +$1.41 (+24%) info
Market Cap: $126.676M info
OPRX
Mar 05, 2026, 5:04 PM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $7.83
Real-time Price: $7.34 info
Change: -$0.4879 (-6%) info
Market Cap: $126.676M info
OPRX
Mar 05, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.82
Real-time Price: $7.34 info
Change: -$0.4779 (-6%) info
Market Cap: $126.676M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets